Patent · US Active

HER2 binders

US10159760B2 · kind B2 · utility

3Cited by
10References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 29, 2016
Grant dateDec 25, 2018
Priority date
Expiry dateAug 12, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K14/71
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Imaging agents comprising an isolated polypeptide conjugated with a radionucleide and a chelator; wherein the isolated polypeptide binds specifically to HER2, or a variant thereof; and methods for preparing and using these imaging agents.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.